Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruediger Liersch

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|August 28, 2007
Lymphangiogenesis in development and diseaseRuediger Liersch, Michael Detmar
Scientific Reports|November 15, 2012
The miR-290-295 cluster suppresses autophagic cell death of melanoma cellsYong Chen, Ruediger Liersch, Michael Detmar
Blood|October 1, 2005
Induction of lymphatic endothelial cell differentiation in embryoid bodiesRuediger Liersch, Filip Nay, Lingge Lu, et al.
British Journal of Haematology|February 4, 2014
Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical useRuediger Liersch, Carsten Müller-Tidow, Wolfgang E Berdel, et al.
International Journal of Oncology|October 19, 2012
Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicatorRuediger Liersch, Satoshi Hirakawa, Wolfgang E Berdel, et al.
Leukemia Research|November 17, 2007
Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemiaRuediger Liersch, Christoph Schliemann, Ralf Bieker, et al.
Current Drug Discovery Technologies|June 10, 2008
Generation of fusion proteins for selective occlusion of tumor vesselsTorsten Kessler, Christian Schwöppe, Ruediger Liersch, et al.
International Journal of Oncology|July 17, 2012
Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factorRuediger Liersch, Jay W Shin, Michael Bayer, et al.
American Journal of Hematology|September 8, 2011
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphomaMichele Pohlen, Hans U Gerth, Ruediger Liersch, et al.
International Journal of Cancer|December 31, 2008
Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancerNiels Reinmuth, Ruediger Liersch, Miriam Raedel, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|August 28, 2007
Lymphangiogenesis in development and diseaseRuediger Liersch, Michael Detmar
Scientific Reports|November 15, 2012
The miR-290-295 cluster suppresses autophagic cell death of melanoma cellsYong Chen, Ruediger Liersch, Michael Detmar
Blood|October 1, 2005
Induction of lymphatic endothelial cell differentiation in embryoid bodiesRuediger Liersch, Filip Nay, Lingge Lu, et al.
British Journal of Haematology|February 4, 2014
Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical useRuediger Liersch, Carsten Müller-Tidow, Wolfgang E Berdel, et al.
International Journal of Oncology|October 19, 2012
Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicatorRuediger Liersch, Satoshi Hirakawa, Wolfgang E Berdel, et al.
Leukemia Research|November 17, 2007
Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemiaRuediger Liersch, Christoph Schliemann, Ralf Bieker, et al.
Current Drug Discovery Technologies|June 10, 2008
Generation of fusion proteins for selective occlusion of tumor vesselsTorsten Kessler, Christian Schwöppe, Ruediger Liersch, et al.
International Journal of Oncology|July 17, 2012
Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factorRuediger Liersch, Jay W Shin, Michael Bayer, et al.
American Journal of Hematology|September 8, 2011
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphomaMichele Pohlen, Hans U Gerth, Ruediger Liersch, et al.
International Journal of Cancer|December 31, 2008
Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancerNiels Reinmuth, Ruediger Liersch, Miriam Raedel, et al.
Pageof 3